PhytoTech Medical Limited (ASX:PYL) MMJ Passes Critical Milestone in MMPR Licensing Process

Warning message

The subscription service is currently unavailable. Please try again later.

Perth, April 9, 2015 AEST (ABN Newswire) - PhytoTech Medical Limited (ASX:PYL) is pleased to report that MMJ has received from Health Canada a "confirmation of readiness letter" that precedes the scheduling of a pre-licensing inspection. 

Highlights

- MMJ Bioscience Inc. ("MMJ") receives pre-inspection readiness request from Health Canada for its Duncan facility that traditionally precedes the scheduling of a pre-licence.

- There are currently only 22 companies holding facilities licensed to produce medical cannabis ("MC") in Canada under the MMPR, with MMJ-PYL on track to become one of the next.

- Confidence in estimates of MC revenues greatly enhanced, expected timeline shortened

- PhytoTech Medical Limited to invest CDN$275,000 in MMJ and, subject to conditions, advance a loan to MMJ of up to A$1,000,000 to fast track both Cannabidiol ("CBD") pill sales in Europe and the grant of a MMPR licence to MMJ's Canadian...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://www.abnnewswire.net/press/en/79710/PhytoTech_Medical_Limited_(ASX:PYL)_MMJ_Passes_Critical_Milestone_in_MMPR_Licensing_Process.html